Internship as a Software Quality Assurance Engineer

Abstract

During this pandemic the world has changed a lot and left us on a thought of im- portance that how much health tech is important for the survival of humanity. So along with other revolution, companies that are working on this industry are more focused than before to make noticeable changes to people’s life. I am lucky to be working on such a project that was invested on this over such a big scale. The company name is Galapagos NV. A bio-pharmaceutical business called Galapagos Health NV is situated in Mechelen, Belgium. The business is concentrated on creating novel therapeutics to address a variety of illnesses with unmet medical requirements, such as inflammatory and fibrotic diseases. One of the main items offered by the business is filgotinib, an oral JAK1 inhibitor used to treat a number of inflammatory diseases such rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. Clinical trials on filgotinib pro- duced encouraging results, and it has been given European and Japanese approval for use. GLPG1690, a selective autotaxin inhibitor for the treatment of idiopathic pulmonary fibrosis, and MOR106, an antibody targeting IL-17C for the treatment of atopic dermatitis, are two further therapeutic candidates that Galapagos Health NV is working on. In 1999, the business was established.